AAAAAA

   
Results: << | 201-225 | 226-250 | 251-275 | 276-300 | >>

Table of contents of journal: The *Prostate

Results: 226-250/1162

Authors: Smith, P Rhodes, NP Ke, YQ Foster, CS
Citation: P. Smith et al., Modulating effect of estrogen and testosterone on prostatic stromal cell phenotype differentiation induced by noradrenaline and doxazosin, PROSTATE, 44(2), 2000, pp. 111-117

Authors: Pacis, RA Pilat, MJ Pienta, KJ Wojno, K Raz, A Hogan, V Cooper, CR
Citation: Ra. Pacis et al., Decreased galectin-3 expression in prostate cancer, PROSTATE, 44(2), 2000, pp. 118-123

Authors: Kassen, AE Sensibar, JA Sintich, SM Pruden, SJ Kozlowski, JM Lee, C
Citation: Ae. Kassen et al., Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: Role of heparin/heparan-degrading enzymes, PROSTATE, 44(2), 2000, pp. 124-132

Authors: Rubio, N Villacampa, MM El Hilali, N Blanco, J
Citation: N. Rubio et al., Metastatic burden in nude mice organs measured using prostate tumor PC-3 cells expressing the luciferase gene as a quantifiable tumor cell marker, PROSTATE, 44(2), 2000, pp. 133-143

Authors: Oberley, TD Zhong, WX Szweda, LI Oberley, LW
Citation: Td. Oberley et al., Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium, PROSTATE, 44(2), 2000, pp. 144-155

Authors: Leung, SYL Jackson, J Miyake, H Burt, H Gleave, ME
Citation: Syl. Leung et al., Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors, PROSTATE, 44(2), 2000, pp. 156-163

Authors: Schwab, TS Stewart, T Lehr, J Pienta, KJ Rhim, JS Macoska, JA
Citation: Ts. Schwab et al., Phenotypic characterization of immortalized normal and primary tumor-derived human prostate epithelial cell cultures, PROSTATE, 44(2), 2000, pp. 164-171

Authors: Plonowski, A Schally, AV Varga, JL Rekasi, Z Hebert, F Halmos, G Groot, K
Citation: A. Plonowski et al., Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways, PROSTATE, 44(2), 2000, pp. 172-180

Authors: Vetvicka, V Vetvickova, J Fusek, M
Citation: V. Vetvicka et al., Role of procathepsin D activation peptide in prostate cancer growth, PROSTATE, 44(1), 2000, pp. 1-7

Authors: Rhodes, L Ding, VDH Kemp, RK Khan, MS Nakhla, AM Pikounis, B Rosner, W Saunders, HM Feeney, WP
Citation: L. Rhodes et al., Estradiol causes a dose-dependent stimulation of prostate growth in castrated beagle dogs, PROSTATE, 44(1), 2000, pp. 8-18

Authors: Harris, MT Feldberg, RS Lau, KM Lazarus, NH Cochrane, DE
Citation: Mt. Harris et al., Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate, PROSTATE, 44(1), 2000, pp. 19-25

Authors: Johansson, CJ Gunnarsson, PO
Citation: Cj. Johansson et Po. Gunnarsson, Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer, PROSTATE, 44(1), 2000, pp. 26-30

Authors: Xie, W Wong, YC Tsao, SW
Citation: W. Xie et al., Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat, PROSTATE, 44(1), 2000, pp. 31-39

Authors: Mahapokai, W Xue, Y van Garderen, E van Sluijs, FJ Mol, JA Schalken, JA
Citation: W. Mahapokai et al., Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog, PROSTATE, 44(1), 2000, pp. 40-48

Authors: Ponniah, S Arah, I Alexander, RB
Citation: S. Ponniah et al., PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome, PROSTATE, 44(1), 2000, pp. 49-54

Authors: Slusher, BS Tiffany, CW Merion, A Lapidus, RG Jackson, PF
Citation: Bs. Slusher et al., Suramin potently inhibits the enzymatic activity of PSM, PROSTATE, 44(1), 2000, pp. 55-60

Authors: Fraser, SP Grimes, JA Djamgoz, MBA
Citation: Sp. Fraser et al., Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of strongly and weakly metastatic cell lines, PROSTATE, 44(1), 2000, pp. 61-76

Authors: Pirtskhalaishvili, G Nelson, JB
Citation: G. Pirtskhalaishvili et Jb. Nelson, Endothelium-derived factors as paracrine mediators of prostate cancer progression, PROSTATE, 44(1), 2000, pp. 77-87

Authors: Coffey, DS
Citation: Ds. Coffey, Morris Pollard: A pioneer in developing animal models for prostate cancer, PROSTATE, 43(4), 2000, pp. 245-246

Authors: Hesburgh, TM
Citation: Tm. Hesburgh, Special issue: Festschrift in honor of Dr. Morris Pollard - Introduction, PROSTATE, 43(4), 2000, pp. 247-247

Authors: Thompson, TC Timme, TL Park, SH Yang, G Ren, CZ
Citation: Tc. Thompson et al., Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease, PROSTATE, 43(4), 2000, pp. 248-254

Authors: Johnson, MA Hernandez, I Wei, YL Greenberg, N
Citation: Ma. Johnson et al., Isolation and characterization of mouse probasin: An androgen-regulated protein specifically expressed in the differentiated prostate, PROSTATE, 43(4), 2000, pp. 255-262

Authors: van Weerden, WM Romijn, JC
Citation: Wm. Van Weerden et Jc. Romijn, Use of nude mouse xenograft models in prostate cancer research, PROSTATE, 43(4), 2000, pp. 263-271

Authors: Waters, DJ Shen, SR Glickman, LT
Citation: Dj. Waters et al., Life expectancy, antagonistic pleiotropy, and the testis of dogs and men, PROSTATE, 43(4), 2000, pp. 272-277

Authors: Zhang, XJ Lee, C Ng, PY Rubin, M Shabsigh, A Buttyan, R
Citation: Xj. Zhang et al., Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein, PROSTATE, 43(4), 2000, pp. 278-285
Risultati: << | 201-225 | 226-250 | 251-275 | 276-300 | >>